Atlas Trials

A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium

Clinical trial NCT00949455 · UNKNOWN

Trial details

NCT number
NCT00949455
Sponsor
Queen Mary University of London
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2009-03-01
Primary completion
2015-07-01
Enrollment
204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.